Companies see a commercial opportunity in creating new ways to administer drugs to patients – in space.

The Pulse Report highlights AI’s growing role in preclinical and translational development as biopharma companies seek ...

JW Pharmaceutical highlighted the therapeutic potential of DDC-02 in multiple neurodevelopmental disorder models at WODC USA ...

FDA instability, staff turnover, and evolving review standards are reshaping drug development. Richard Pazdur, formerly with ...

Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.

Cancer drug development has never moved faster. Yet, for too many patients, the next treatment decision still begins with ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...

Regulatory pressure from GxP, 21 CFR Part 11, and AI/ML guidance elevates requirements for audit trails, data lineage, validation, and life cycle controls that hybrid architectures can operationalize.

Dynamic Vapor Sorption (DVS) is a potent analytical technique used in the pharmaceutical industry to determine how much vapor a sample absorbs or desorbed under regulated temperature and humidity ...

An ASSOCHAM report projects India's pharma market to cross USD 120 billion by 2030, driven by global exports, AI drug discovery, biosimilars, and a shift from generics to core biotech innovation.

Pharmaceutical stocks can be excellent defensive investments during times of economic uncertainty, and many pharma stocks are ...